Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stereotaxis Announces Successful Launch of Genesis Robotic Magnetic Navigation System at Hospital da Luz in Lisbon

Hospital da Luz in Portugal successfully treated patients using Stereotaxis' Genesis Robotic Magnetic Navigation System for cardiac procedures.Quiver AI SummaryStereotaxis has announced that the Hospital...

STXS : 2.06 (+1.48%)
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

STXS : 2.06 (+1.48%)
Stereotaxis Reports 2024 Third Quarter Financial Results

STXS : 2.06 (+1.48%)
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology

STXS : 2.06 (+1.48%)
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024

STXS : 2.06 (+1.48%)
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

STXS : 2.06 (+1.48%)
Stereotaxis (STXS) Q2 2022 Earnings Call Transcript

STXS earnings call for the period ending June 30, 2022.

STXS : 2.06 (+1.48%)
Stereotaxis Reports 2022 Second Quarter Financial Results

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+1.48%)
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline

ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+1.48%)
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022

ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.06 (+1.48%)

Barchart Exclusives

5 Stocks to Snag Now as Dealmaking Returns to Wall Street
With anticipation of heightened deals in the coming year, here are 5 stocks that can benefit. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar